Market Research Logo

Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review

Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and


Section 1 - About the Company
Gilead Sciences Inc - Key Facts
Gilead Sciences Inc - Key Employees
Gilead Sciences Inc - Key Employee Biographies
Gilead Sciences Inc - Major Products and Services
Gilead Sciences Inc - History
Gilead Sciences Inc - Company Statement
Gilead Sciences Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 - Company Analysis
Company Overview
Gilead Sciences Inc - Business Description
Geographical Segment: Europe
Performance
Geographical Segment: Other International
Performance
Geographical Segment: US
Performance
Gilead Sciences Inc - Corporate Strategy
Gilead Sciences Inc - SWOT Analysis
SWOT Analysis - Overview
Gilead Sciences Inc - Strengths
Gilead Sciences Inc - Weaknesses
Gilead Sciences Inc - Opportunities
Gilead Sciences Inc - Threats
Gilead Sciences Inc - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Gilead Sciences Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
Mar 05, 2019: Gilead announces senior management change
Mar 04, 2019: etectRx's Innovative ID-Cap System Selected to Track Medication Ingestion in HIV Prevention Study
Mar 01, 2019: MaxCyte Announces Multi-Drug Clinical & Commercial Agreement with Kite, a Gilead Company
Feb 26, 2019: Gilead Sciences launches Age Positively Initiative to address unique challenges of Aging Population living with HIV
Feb 04, 2019: Gilead Sciences announces fourth quarter and full year 2018 financial results
Jan 17, 2019: PhRMA welcomes Genentech and Gilead Sciences to association
Dec 10, 2018: Gilead appoints current Roche Pharmaceuticals CEO as new CEO and chairman
Dec 10, 2018: Gilead Sciences names Daniel O’Day Chairman and Chief Executive Officer
Dec 03, 2018: Gilead Sciences announces recipients of Asia Rainbow grants program
Section 6 - Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Gilead Sciences Inc, Key Facts
Gilead Sciences Inc, Key Employees
Gilead Sciences Inc, Key Employee Biographies
Gilead Sciences Inc, Major Products and Services
Gilead Sciences Inc, History
Gilead Sciences Inc, Other Locations
Gilead Sciences Inc, Subsidiaries
Gilead Sciences Inc, Joint Venture
Gilead Sciences Inc, Key Competitors
Gilead Sciences Inc, Ratios based on current share price
Gilead Sciences Inc, Annual Ratios
Gilead Sciences Inc, Annual Ratios (Cont...1)
Gilead Sciences Inc, Annual Ratios (Cont...2)
Gilead Sciences Inc, Interim Ratios
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Gilead Sciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Gilead Sciences Inc, Performance Chart (2014 - 2018)
Gilead Sciences Inc, Ratio Charts
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report